Northeast Regional Epilepsy Group
New York, 10017, United States
NCT Number: NCT07344766
An outpatient randomized controlled clinical trial conducted at the Northeast Regional Epilepsy Group's PNES Program, involving mental health clinicians certified in PE and trained in administering PsychoEd.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
New York, 10017, United States
A randomized parallel group trial was utilized to compare two therapeutic interventions for PNES, PE or PsychoEd, both delivered remotely via teletherapy. Each psychotherapeutic modality provided 12, 90-minute sessions. Seizure frequency was the primary outcome measure. Secondary outcome measures were depression (Beck Depression Inventory) and post-traumatic stress symptomatology (Post-Traumatic Disorder Diagnostic Scale and PTSD Checklist). Data was collected prospectively, including baseline measures before initiating treatment, upon treatment completion, and at follow-up intervals of 3, 6, and 12-months post-treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
English-speaking adults (18 years and older) Confirmed diagnosis of PNES through video-EEG monitoring Confirmed diagnosis of current PTSD At least one psychogenic non-epileptic seizure in the month prior to beginning treatment.
Exclusion criteria
Concurrent mixed epilepsy and PNES or video EEG findings that cannot clearly distinguish epilepsy and PNES Active suicidality Active psychotic symptoms Active substance or alcohol use or dependence that could interfere with participation in therapy Application for disability
-
Prolonged exposure is a form of cognitive behavioral treatment that uses exposure to avoided memories and reminders
A combination of psychoeducation about PNES and skills for emotional regulation and relaxation.
Other names: PsychoEd for PNES
Time frame: From enrollment until session 12 and at 3, 6 and 12month follow up
frequency of nonepileptic seizures (PNES) per month
Time frame: From enrollment to session 12 and at 3, 6 and 12 months follow up
Self-report inventory of depressive symptoms 0-13: minimal depression, 14-19: mild, 20-28: moderate, 29-63: severe
Time frame: From enrollment until session 12 of treatment and at 3, 6 and 12 months follow up
Post traumatic stress symptom checklist scores range from 0-80, higher score means worse outcome
Time frame: From enrollment until session 12 of treatment and at 3, 6 and 12 months follow up
post traumatic diagnostic scale 0: No symptoms, 1-10: Mild symptoms, 11-20: Moderate symptoms, 21-35: Moderate to severe symptoms, >36: Severe symptoms.
Time frame: From enrollment through session 12 of treatment and at 3, 6 and 12 months follow up
Clinician-Administered PTSD Scale for DSM 5. Severity rating: 0: absent, 1: mild, 2: moderate, 3: severe, 4: extreme
Northeast Regional Epilepsy Group
Other
Pilot Prolonged Exposure Teletherapy Treatment Trial for Psychogenic Nonepileptic Seizures (PNES) and Post-traumatic Stress Disorder (PTSD): A Randomized Clinical Trial
Acronym: PNES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02821208
Nervous System Diseases, Neurologic Manifestations
Bordeaux, France
View Trial DetailsNCT06795659
Combat Disorders, Mental Disorders
San Antonio, Texas, United States
View Trial DetailsNCT06669442
Combat Disorders, Mental Disorders
Miami, Florida, United States
View Trial DetailsNCT06861400
Acceptability, Adaptive Self-reflection
Syracuse, New York, United States
View Trial Details